Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study

Autor: Athivada Soto Thammavong, Raphaële Renard-Penna, Gilles Pasticier, Jean-Philippe Fendler, Flavie Bratan, Romain Boutier, Hervé Lang, Pascal Eschwege, Jochen Walz, Arnault Viller, Myriam Decaussin-Petrucci, Alain Ruffion, Nicolas Barry Delongchamps, Y. Lebras, François Cornud, Pierre Mozer, Jean-Michel Correas, Olivier Rouvière, Laurent Lemaitre, Michel Claudon, Paul C. Moldovan, Marine Dubreuil-Chambardel, Fanny Cros, Pierre Colin, Bernard Malavaud, Sebastien Crouzet, Hocine Habchi, Ahmed Khairoune, F Lefèvre, Anne-Marie Schott, Nicolas Grenier, G. Pagnoux, S. Brunelle, Marc Colombel, Laurent Magaud, Laurent Remontet, Philippe Camparo, Philippe Puech, François Cornelis, Florence Mège-Lechevallier, Muriel Rabilloud, Pierre Nevoux, E. Potiron, Daniel Portalez, Marc-Olivier Timsit, Nicolas Mottet, Gaelle Fiard, Jean-Luc Descotes, Catherine Roy, Philippe Hallouin

Publikováno v: Lancet Oncology
Lancet Oncology, Elsevier, 2019, 20 (1), pp.100-109. ⟨10.1016/S1470-2045(18)30569-2⟩
Lancet Oncology, 2019, 20 (1), pp.100-109. ⟨10.1016/S1470-2045(18)30569-2⟩

Summary Background Whether multiparametric MRI improves the detection of clinically significant prostate cancer and avoids the need for systematic biopsy in biopsy-naive patients remains controversial. We aimed to investigate whether using this appro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8265f09a9d48dbeb67385ce450f07cf4
https://doi.org/10.1016/s1470-2045(18)30569-2